Research Progress on Hyperammonia-induced Hepatic Encepha-lopathy

Abstract

Abstract:Hepatic encephalopathy （HE） is a serious complication of acute or chronic liver failure，caused by many reasons （i.e. ammonia，multiple neurotoxins，false neurotransmitters and benzodiazepine-like compounds）. Evidences suggest that ammonia plays a major role in pathogenesis of HE. Hyperammonia up-regulates gene expression of peripheral-type benzodiazepine receptor （PTBR），glucose tranporter-1 （GLUT-1），aquaporin-4 （AQP4），and Na⁺/K⁺-ATPase in astrocytes；alters the phosphorylation state of the microtubule-associated protein-2 （MAP-2） and the expression of N-methyl-D-aspartate （NMDA） receptor；induces increase of NO，therefore astrocytic disfunction. It was reported previously that ammonia increased production of ouabain-like compounds and Na⁺/K⁺-ATPase activity in astrocytes. Research to the relationship of these factors will help us to understand the underlying mechanisms of ammonia-induced astrocytic disfunction and eventually contribute to the new strategies of prevention and therapy of HE.

Key words:hepatic encephalopathy （HE）,peripheral-type benzodiazepine receptor（PTBR）,glucose tranporter-1（GLUT-1）,aquaporin-4（AQP4）,Na⁺/K⁺-ATPase,microtubule-associated protein（MAP-2）,N-methyl-D-aspartate （NMDA） receptor,nitric oxide （NO）

CLC Number:

XUE Zhan-xia, PENG Liang. Research Progress on Hyperammonia-induced Hepatic Encepha-lopathy[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(4): 33-41.

References

1 Wright G, Chattree A, Jalan R. Management of hepatic encephalopathy [J]. Int J Hepatol, 2011, 2011: 841407.

2 Brandman D, Biggins SW, Hameed B, et al. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality [J]. Liver Int, 2012, 32(1): 158-164.

3 Cárdenas A, Ginès P. Portal hypertension [J]. Curr Opin Gastroenterol, 2009, 25(3): 195-201.

4 Faint V. The pathophysiology of hepatic encephalopathy [J]. Nurs Crit Care, 2006, 11(2): 69-74.

5 Regina Corbalán, Mariluz Hernández-Viadel, Marta Llansola, et al. Chronic hyperammonemia alters protein phosphorylation and glutamate receptor-associated signal transduction in brain [J]. Neurochem Int, 2002, 41(2-3): 103-108.

6 Rabinstein AA. Treatment of brain edema in acute liver failure [J]. Curr Treat Options Neuro, 2010, 12(2): 129-141.

7 Gutierrez JA, Norenberg MD. Ultrastructural study of methionine sulfoximine-induced Alzheimer type II astrocytosis [J]. Am J Pathol, 1977, 86(2): 285-300.

8 Rao KV, Norenberg MD. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia [J]. Metab Brain Dis, 2001, 16(1-2): 67-78.

9 Albrecht J, Zielińska M, Norenberg MD. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal [J]. Biochem Pharmacol, 2010, 80(9): 1303-1308.

10 Claudia Zwingmann, Paul Desjardins, Astrocytic Hazell, et al. Reduced expression of astrocytic glycine transporter (Glyt-1) in acute liver failure [J]. Metab Brain Dis, 2002, 17(4): 263-273.

11 Rama Rao KV, Jayakumar AR, Norenberg MD. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes [J]. Neurochem Int, 2005, 47(1-2): 31-38.

12 Pichili VB Reddy, Rama KakulavarapuV Rao, Michael D Norenberg. Inhibitors of the mitochondrial permeability transition reduce ammonia-induced cell swelling in cultured astrocytes [J]. J Neurosci Res, 2009, 87(12): 2677-2685.

13 Claudia Zwingmann, Roger Butterworth. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy [J]. Neurochem Int, 2005, 47(1-2): 19-30.

14 Görg B, Qvartskhava N, Bidmon HJ, et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy [J]. Hepatology, 2010, 52(1): 256-265.

15 Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy [J]. Gut, 2008, 57(8): 1156-1165.

16 Häussinger D. Hepatic encephalopathy [J]. Acta Gastroenterol Belg, 2010, 73(4): 457-464.

17 Jayakumar AR, Panickar KS, Murthy ChR, et al. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes [J]. J Neurosci, 2006, 26(18): 4774-4784.

18 Mireille Bélanger, Paul Desjardins, Nicolas Chatauret, et al. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure [J]. J Hepatol, 2005, 42(5): 694-699.

19 Mireille Belanger, Paul Desjardins, Nicolas Chatauret, et al. Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure [J]. Glia, 2006, 53(5): 557-562.

20 Eefsen M, Jelnes P, Schmidt LE, et al. Brain expression of the water channels aquaporin-1 and -4 in mice with acute liver injury, hyperammonemia and brain edema [J]. Metab Brain Dis, 2010, 25(3): 315-323.

21 Xue Z, Li B, Gu L, et al. Increased Na, K-ATPase alpha2 isoform gene expression by ammonia in astrocytes and in brain in vivo [J]. Neurochem Int, 2010, 57(4): 395-403.

22 Claudia Zwingmann, Paul Desjardins, Alan Hazell, et al. Reduced expression of astrocytic glycine transporter (Glyt-1) in acute liver failure [J]. Metab Brain Dis, 2002, 17(4): 263-273.

23 Julia Wendon, William Lee. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management [J]. Neurocrit Care, 2008, 9(1): 97-102.

24 Krueger KE, Papadopoulos V. Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis [J]. Annu Rev Pharmacol Toxicol, 1992, 32: 211-237.

25 Doris PA, Stocco DM. An endogenous digitalis-like factor derived from the adrenal gland: studies of adrenal tissue from various sources [J]. Endocrinology, 1989, 125(5): 2573-2579.

26 Yossef Itzhak, Michael D Norenberg. Ammonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H] PK 11195 [J]. Neurosci Lett, 1994, 177(1-2): 35-38.

27 Perrin A, Brasmes B, Chambaz EM, et al. Bovine adrenocortical cells in cultures synthesize an ouabain-like compound [J]. Mol Cell Endocrinol, 1997, 126(1): 7-15.

28 David Lichtstein, Michael Steinitz, Irith Gati, et al. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor [J]. Life Sci, 1998, 62(23): 2109-2126.

29 Kala G, Kumarathasan R, Peng L, et al. Stimulation of Na+ ,K+-ATPase activity, increase in potassium uptake, and enhanced production of ouabain-like compounds in ammonia-treated mouse astrocytes [J]. Neurochem Int, 2000, 36(3): 203-211.

30 Hans-Georg Joost, Graeme I Bell, James D Best, et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators [J]. Am J Physiol Endocrinol Metab, 2002, 282(4): E974-E976.

31 Yu Shun, Zhao Tong, Guo Miao, et al. Hypoxic preconditioning up-regulates glucose transport activity and glucose transporter (GLUT1 and GLUT3) gene expression after acute anoxic exposure in the cultured rat hippocampal neurons and astrocytes [J]. Brain Res, 2008, 1211: 22-29.

32 陈铮, 陈惠金, 蒋明华, 等. 脑缺氧缺血对葡萄糖转运蛋白1基因和葡糖糖转运蛋白3基因表达的影响 [J]. 实用儿科临床杂志, 2005, 20(1): 39-41.

33 聂琴, 辛现良, 耿美玉. 葡萄糖载体蛋白-1研究进展 [J]. 中国药理学通报, 2010, 26(10): 1267-1270.

34 Fuminori Umenishi, Verkman AS. Isolation and functional analysis of alternative promoters in the human aquaporin-4 water channel gene [J]. Genomics, 1998, 50(3): 373-377.

35 Eefsen M, Jelnes P, Schmidt LE, et al. Brain expression of the water channels aquaporin-1 and -4 in mice with acute liver injury, hyperammonemia and brain edema [J]. Metab Brain Dis, 2010, 25(3): 315-323.

36 Vizuete ML, Venero JL, Vargas C, et al. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema [J]. Neurobiol Dis, 1999, 6(4): 245-258.

37 Kakulavarapu V Rama Rao, Jayakumar Arumugant R, Tong Xiaoying, et al. Brain aquaporin-4 in experimental acute liver failure [J]. J Neuropathol Exp Neurol, 2010, 69(9): 869-879.

38 Wright G, Soper R, Brooks HF, et al. Role of aquaporin-4 in the development of brain oedema in liver failure [J]. J Hepatol, 2010, 53(1): 91-97.

39 Kathleen J Sweadner. Overlapping and diverse distribution of Na/K-ATPase isozyme in neurons and glia [J]. Can J Physiol Pharmacol, 1992, 70: S225-S229.

40 Katsutoshi Taguchi, Haruko Kumanogoh, Shun Nakamura, et al. Ouabain-induced isoform-specific localization change of the Na+, K+-ATPase alpha subunit in the synaptic plasma membrane of rat brain [J]. Neurosci Lett, 2007, 413(1): 42-45.

41 Peng Liang, Huang Rong, Zhang Shiquen, et al. Ouabain binding kinetics and FXYD7 expression in astrocytes and neurons in primary cultures: implications for cellular contributions to extracellular K+ homeostasis? [J]. Neuron Glia Biol, 2010, 6(2): 127-135.

42 Kathi Geering. Function of FXYD proteins, regulators of Na, K-ATPase [J]. J Bioenerg Biomembr, 2005, 37(6): 387-392.

43 Delprat B, Bibert S, Geering K. FXYD proteins: novel regulators of Na,K-ATPase [J]. Med Sci (Paris), 2006, 22(6-7): 633-638.

44 Peng Liang, Martin-vasallo Pablo, Kathleen J Sweadner. Isoforms of Na, K-ATPase alpha and beta subunits in the rat cerebellum and in granule cell cultures [J]. J Neurosci, 1997, 17(10): 3488–3502.

45 Cholet N, Pellerin L, Magistretti PJ, et al. Similar perisynaptic glial localization for the Na+, K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex [J]. Cereb Cortex, 2002, 12(5): 515-525.

46 Amy E Moseley, Steve P Lieske, Randal K Wetzel, et al. The Na/K-ATPase α2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice [J]. J Biol Chem, 2003, 278(7): 5317-5324.

47 Patrizia Ferrari, Mara Ferrandi, Givoanni Valentini, et al. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension [J]. Am J Physiol Regul Integr Comp Physiol, 2006, 290(3): R529-535.

48 Tian Jiang, Cai Ting, Yuan Zhaokan, et al. Binding of Src to Na+/K+-ATPase forms a functional signaling complex [J]. Mol Biol Cell, 2006, 17(1): 317-326.

49 Tara L Haas. Molecular control of capillary growth in skeletal muscle [J]. Can J Appl Physiol, 2002, 27(5): 491-515.

50 Zhang Deyong, Wang Yan, Lau Chu-Pak, et al. Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels [J]. Cell Signal, 2008, 20(10): 1815-1821.

51 Liu Jiang, Shapiro Joseph I. Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications [J]. Pathophysiology, 2007, 14(3-4): 171-181.

52 Liu L, Zhao X, Pierre SV, et al. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes [J]. Am J Physiol Cell Physiol, 2007, 293(5): C1489-C1497.

53 Felipo Vicente, Grau Eugenio, Maria-Dolores Miñana, et al. Ammonium injection induces an N-methyl-D-aspartate receptor-mediated proteolysis of the microtubule-associated protein MAP-2 [J]. J Neurochem, 1993, 60(5): 1626-1630.

54 Sáez Rosana, Llansola Marta, Felipo Vicente. Chronic exposure to ammonia alters pathways modulating phosphorylation of microtubule-associated protein 2 in cerebellar neurons in culture [J]. J Neurochem, 1999, 73(6): 2555-2562.

55 Felipo V, Grau E, Miñana MD, et al. Activation of NMDA receptor mediates the toxicity of ammonia and the effects of ammonia on the microtubule-associated protein MAP-2 [J]. Adv Exp Med Biol, 1993, 341: 83-93.

56 Zamora-Leon SP, Lee G, Davies P, et al. Binding of fyn to MAP-2c through an SH3 binding domain. regulation of the interaction by ERK2 [J]. J Biol Chem, 2001, 276(43): 39950-39958.

57 Vicente Felipo, Eugenio Grau, Maria-Dolores Miñana, et al. Hyperammonemia decreases protein-kinase-C-dependent phosphorylation of microtubule-associated protein 2 and increases its binding to tubulin [J]. Eur J Biochem, 1993, 214(1): 243-249.

58 Llansola M, Erceg S, Felipo V. Chronic exposure to ammonia alters the modulation of phosphorylation of microtubule-associated protein 2 by metabotropic glutamate receptors 1 and 5 in cerebellar neurons in culture [J]. Neuroscience, 2005, 133(1): 185-191.

59 Marta Llansola, Regina Rodrigo, Pilar Monfort, et al. NMDA receptors in hyperammonemia and hepatic encephalopathy [J]. Metab Brain Dis, 2007, 22(3-4): 321-335.

60 Wojciech Hilgier, Michal Wegrzynowicz, Michal Maczewski, et al. Effect of glutamine synthesis inhibition with methionine sulfoximine on the nitric oxide-cyclic GMP pathway in the rat striatum treated acutely with ammonia: a microdialysis study [J]. Neurochem Res, 2008, 33(2): 267-272.

61 Nomura Yasuyuki, Kitamura Yoshihisa. Inducible nitric oxide synthase in glial cells [J]. Neurosci Res, 1993, 18(2): 103-107.

62 Isable Suárez, Guillermo Bodega, Miguel Rubio, et al. Induction of NOS and nitrotyrosine expression in the rat striatum following experimental hepatic encephalopathy [J]. Metab Brain Dis, 2009, 24(3): 395-408.

63 Camila C Scorticati, Juan C Perazzo, Valeria Rettori, et al. Role of ammonia and nitric oxide in the decrease in plasma prolactin levels in prehepatic portal hypertensive male rats [J]. Neuroimmunomodulation, 2006, 13(3): 152-159.

64 Jiang W, Desjardins P, Butterworth RF. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure [J]. Neurochem Int, 2009, 55(1-3): 124-128.

65 Rodrigo R, Erceg S, Rodriguez-Diaz J, et al. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure [J]. J Neurochem, 2007, 102(1): 51-64.

66 El-Mlili Nisrin, Rodrigo Regina, Naghizadeh Bahareh, et al. Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium-calmodulin kinase II [J]. J Neurochem, 2008, 106(3): 1440-1449.

[1]	LI Lan, ZHANG Dan-shen.Research Methods of Drug in Vitro Liver Metabolism[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 10-13.
[2]	ZHANG Hao-nan, YANG Hui.Recent Advances in the Research of the Protective Effect of Natural Drugs on Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 14-20.
[3]	YAN Wei, ZHAO Yong-ming.Research Progress on the Influence of Electromagnetic Radiation on Nerve Cells[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 21-28.
[4]	LIU Chang, MENG Xian-yong, DONG Xiao-hua.Research Progress on Pathogenesis and Therapeutic Drugs of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 36-40.
[5]	HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64.
[6]	XU Jia-qi, ZHANG Hai-hong.Research Progress on Physiological Activity of Patchouli[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 27-32.
[7]	YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53.
[8]	SUN Yi, HOU Xue-qin, WANG Fu-gang.Research Progress of Danggui Shaoyao Powder in Improving Cognitive Function[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 42-46.
[9]	QI Gi，WU Hong-li，QI Quan, et al.Correlation between Progesterone Supplementation in the Early Pregnancy and Incidence of Gestational Diabetes Mellitus[J]. Acta Neuropharmacologica, 2019, 9(6): 6-10.
[10]	ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pulmonary Tuberculosis[J]. Acta Neuropharmacologica, 2019, 9(6): 11-14.
[11]	ZHANG Dan-shen1，MA Jia-cheng2.Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, 2019, 9(6): 15-20.
[12]	ZHANG Dan-shen，JIN Shan.Methods and Evaluation of Animal Models of Induced Silicosis[J]. Acta Neuropharmacologica, 2019, 9(6): 21-25.
[13]	LIU Hui-juan，BAI ming，MIAO Ming-san.Application and Analysis of Chinese Patent Medicine Containing Gastrodia elata Blume[J]. Acta Neuropharmacologica, 2019, 9(6): 26-30.
[14]	LIU Xuan, TENG Jin-liang.Effect of Dexmedetomidine on Perioperative Analgesia[J]. Acta Neuropharmacologica, 2019, 9(6): 41-46.
[15]	LIANG Yu-fei，ZHANG Xin-xin，ZHAO Li-yan，et al.Discussed the Application of Curcumin Combined with Piperine Based on the Metabolic Characteristics of Curcumin[J]. Acta Neuropharmacologica, 2019, 9(6): 47-57.